|
|
Article: Raptor Pharmaceutical Expands Board of Directors.
- Article from:
- Cancer Weekly
- Article date:
- October 13, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (NASDAQ:RPTPD), announced the appointment of Llew Keltner, M.D., Ph.D., to the Company's board of directors. Dr. Keltner is currently CEO and President of Light Sciences Oncology, a privately-held biotechnology company developing a late-stage, light-activated therapy for hepatocellular cancer and other solid tumors. He is also CEO of EPISTAT, an international healthcare technology transfer, corporate risk management and healthcare strategy company that he founded in 1972 (see also Cancer).
Christopher M. Starr, Ph.D., CEO of Raptor stated, "On behalf of the board and the executive management of Raptor, I ...